Remarkably, several reports have described that ~70% of HCC harbor mutations in THRα or THRβ and several tumors exhibit mutation in both loci (Chan & Privalsky, 2006; Kim & Cheng, 1830; Lin et al., 1999). Here, THRA is linked to hepatocellular carcinoma.